157 related articles for article (PubMed ID: 37957052)
21. [Drug-induced hearing loss as a manifestation of drug-induced ototoxicity].
Ostroumova OD; Chikh EV; Rebrova EV; Ryazanova AY; Pereverzev AP
Vestn Otorinolaringol; 2019; 84(4):72-80. PubMed ID: 31579063
[TBL] [Abstract][Full Text] [Related]
22. The Novel Peptide Vaccine GV1001 Protects Hearing in a Kanamycin-induced Ototoxicity Mouse Model.
Kim SY; Jung G; Shim YJ; Koo JW
Otol Neurotol; 2018 Sep; 39(8):e731-e737. PubMed ID: 30015752
[TBL] [Abstract][Full Text] [Related]
23. Transient ischemia/hypoxia enhances gentamicin ototoxicity via caspase-dependent cell death pathway.
Lin CD; Kao MC; Tsai MH; Lai CH; Wei IH; Tsai MH; Tang CH; Lin CW; Hsu CJ; Lin CY
Lab Invest; 2011 Jul; 91(7):1092-106. PubMed ID: 21519324
[TBL] [Abstract][Full Text] [Related]
24. Traditional oriental medicine for sensorineural hearing loss: Can ethnopharmacology contribute to potential drug discovery?
Castañeda R; Natarajan S; Jeong SY; Hong BN; Kang TH
J Ethnopharmacol; 2019 Mar; 231():409-428. PubMed ID: 30439402
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin-induced ototoxicity: From signaling network to therapeutic targets.
Wang X; Zhou Y; Wang D; Wang Y; Zhou Z; Ma X; Liu X; Dong Y
Biomed Pharmacother; 2023 Jan; 157():114045. PubMed ID: 36455457
[TBL] [Abstract][Full Text] [Related]
26. Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor.
Polski B; Sosnowska-Sienkiewicz P; Szydłowski J; Januszkiewicz-Lewandowska D
Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558
[TBL] [Abstract][Full Text] [Related]
27. FGF22 protects hearing function from gentamycin ototoxicity by maintaining ribbon synapse number.
Li S; Hang L; Ma Y
Hear Res; 2016 Feb; 332():39-45. PubMed ID: 26639016
[TBL] [Abstract][Full Text] [Related]
28. Effects of lifetime noise exposure on the middle-age human auditory brainstem response, tinnitus and speech-in-noise intelligibility.
Valderrama JT; Beach EF; Yeend I; Sharma M; Van Dun B; Dillon H
Hear Res; 2018 Aug; 365():36-48. PubMed ID: 29913342
[TBL] [Abstract][Full Text] [Related]
29. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
30. [Otoacoustic emissions--a step closer to understanding cochlear function].
Komazec Z; Milosević D; Filipović D; Dankuc D
Med Pregl; 2001; 54(11-12):539-42. PubMed ID: 11921687
[TBL] [Abstract][Full Text] [Related]
31. Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis.
Núñez-Batalla F; Jáudenes-Casaubón C; Sequí-Canet JM; Vivanco-Allende A; Zubicaray-Ugarteche J
Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(4):255-265. PubMed ID: 35872300
[TBL] [Abstract][Full Text] [Related]
32. Ototoxicity: therapeutic opportunities.
Rybak LP; Whitworth CA
Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
[TBL] [Abstract][Full Text] [Related]
33. Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
Hirose K; Li SZ; Ohlemiller KK; Ransohoff RM
J Assoc Res Otolaryngol; 2014 Aug; 15(4):555-70. PubMed ID: 24845404
[TBL] [Abstract][Full Text] [Related]
34. Combined antioxidants and anti-inflammatory therapies fail to attenuate the early and late phases of cyclodextrin-induced cochlear damage and hearing loss.
Manohar S; Ding D; Jiang H; Li L; Chen GD; Kador P; Salvi R
Hear Res; 2022 Feb; 414():108409. PubMed ID: 34953289
[TBL] [Abstract][Full Text] [Related]
35. Drug-induced hearing loss.
Prescrire Int; 2014 Dec; 23(155):290-4. PubMed ID: 25629145
[TBL] [Abstract][Full Text] [Related]
36. Berberine chloride protects cochlear hair cells from aminoglycoside-induced ototoxicity by reducing the accumulation of mitochondrial reactive oxygen species.
Kim YR; Baek JI; Lee KY; Kim UK
Free Radic Biol Med; 2023 Aug; 204():177-183. PubMed ID: 37119862
[TBL] [Abstract][Full Text] [Related]
37. Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
Tan WJT; Vlajkovic SM
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003734
[TBL] [Abstract][Full Text] [Related]
38. Pattern of ototoxicity in a Nigerian teaching hospital.
Salisu AD; Hasheem MG
Niger J Med; 2010; 19(3):320-3. PubMed ID: 20845639
[TBL] [Abstract][Full Text] [Related]
39. Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.
Garinis AC; Keefe DH; Hunter LL; Fitzpatrick DF; Putterman DB; McMillan GP; Gold JA; Feeney MP
Ear Hear; 2018; 39(1):69-84. PubMed ID: 28708814
[TBL] [Abstract][Full Text] [Related]
40. Aucubin protects mouse cochlear hair cells from cisplatin-induced ototoxicity via activation of the PI3K/AKT/STAT3 pathway.
Jiang Y; Li Z; Ma Q; Dong W; Yao Q; Yu D
Biochem Pharmacol; 2023 Mar; 209():115440. PubMed ID: 36720354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
